Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Aerobic Exercise Performance and Muscle Strength in Statin Users-The LIFESTAT Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Neuromuscular Fatigue and Metabolism during High-Intensity Intermittent Exercise

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Time Trial Performance Is Sensitive to Low-Volume Autologous Blood Transfusion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Dynamic Cerebral Autoregulation Is Maintained during High-Intensity Interval Exercise

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Impact of a Graded Exercise Program on V˙O2peak and Survival in Heart Failure Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Effect of Losartan on the Acute Response of Human Elderly Skeletal Muscle to Exercise

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Simvastatin improves mitochondrial respiration in peripheral blood cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver tissue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Mitochondrial adaptations to high intensity interval training in older females and males

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Determination and validation of peak fat oxidation in endurance-trained men using an upper body graded exercise test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Statins are widely used in both primary and secondary prevention of cardiovascular disease. The treatment increases the risk of muscle pain (myalgia) which can affect muscle function and levels of physical activity. We investigated whether statin-associated myalgia is coupled to impaired aerobic exercise performance including fat oxidation as well as impaired muscle strength.

METHODS: A population-based survey (6000 people) was performed to assess the prevalence of statin-associated myalgia in the Danish population. In addition, 64 statin users in primary prevention with myalgia (M; n = 25; 61 ± 1 yr) or without myalgia (NM; n = 37; 63 ± 1 yr) as well as a control group not taking statins (C; n = 20; 60 ± 2 yr) were enrolled in a cross-sectional study where they performed aerobic exercise and muscle strength tests.

RESULTS: The response rate for the survey was 51% and data showed a prevalence of statin-associated myalgia in 19% of responders using statins. The experimental study showed no difference between the groups in aerobic capacity (C, 29 ± 1 mL O2·min·kg; M, 27 ± 1 mL O2·min·kg; NM, 28 ± 1 mL O2·min·kg) or maximal fat oxidation (C, 247 ± 26 mg·min; M, 295 ± 24 mg·min; NM, 279 ± 17 mg·min). Measurements of strength were similar in all three groups including rate of force development (C, 795 ± 56 N·m·s; M, 930 ± 93 N·m·s; NM, 971 ± 57 N·m·s) and leg extension power (C: 2.6 ± 0.2; M: 2.3 ± 0.1; NM: 2.4 ± 0.1 W·kg). All results are mean ± SEM.

CONCLUSION: Statin users in primary prevention experiencing myalgia do not have impaired aerobic exercise performance or muscle strength compared to nonmyalgic statin users or control subjects.

OriginalsprogEngelsk
TidsskriftMedicine and Science in Sports and Exercise
Vol/bind51
Udgave nummer7
Sider (fra-til)1429-1437
Antal sider9
ISSN0195-9131
DOI
StatusUdgivet - jul. 2019

ID: 59411022